Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Depletion of m6A reader protein YTHDC1 induces dilated cardiomyopathy by abnormal splicing of Titin
Siyun Gao, Haifeng Sun, Kejing Chen, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 23, pp. 10879-10891
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Insight into the structure, physiological function, and role in cancer of m6A readers—YTH domain-containing proteins
Jingyu Liao, Yi Wei, Junnan Liang, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 58
Roles and mechanisms of the m6A reader YTHDC1 in biological processes and diseases
Huaqing Yan, Liqi Zhang, Xiaobo Cui, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 46
RNA modification in cardiovascular disease: implications for therapeutic interventions
Cong Wang, Xuyang Hou, Qing Guan, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 29
RNA-binding proteins in cardiovascular biology and disease: the beat goes on
Mirko Völkers, Thomas Preiß, Matthias W. Hentze
Nature Reviews Cardiology (2024) Vol. 21, Iss. 6, pp. 361-378
Closed Access | Times Cited: 14
Histone acetyltransferase Kat2a regulates ferroptosis via enhancing Tfrc and Hmox1 expression in diabetic cardiomyopathy
Juan Zhen, Xia Sheng, Tianlong Chen, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 6
Open Access | Times Cited: 11
RNA modifications in cardiovascular health and disease
Aikaterini Gatsiou, Konstantinos Stellos
Nature Reviews Cardiology (2022) Vol. 20, Iss. 5, pp. 325-346
Closed Access | Times Cited: 34
Reading the m6A-encoded epitranscriptomic information in development and diseases
Yunbing Chen, Ziyu Zhou, Yanxi Chen, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Regulatory mechanisms of m6A methylation in dilated cardiomyopathy
Hao Zhang, Haiyang Guo, Fengjiao Han, et al.
American Journal of Translational Research (2025) Vol. 17, Iss. 1, pp. 47-59
Closed Access
Methylations in dilated cardiomyopathy and heart failure
Cong Qin, Yansong Qin, Shanshan Zhou
Frontiers in Cardiovascular Medicine (2025) Vol. 12
Open Access
M6A reader protein YTHDF3 regulates cardiomyocyte death and atrophy by modulating the alternative splicing program
Aakash Gaur, Sakshi Chaudhary, Rakesh Kumar Sharma, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Identification and verification of IGFBP3 and YTHDC1 as biomarkers associated with immune infiltration and mitophagy in hypertrophic cardiomyopathy
Yao Li, Wei Zhang, Yan Dai, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 18
The Effect of N6-Methyladenosine Regulators and m6A Reader YTHDC1-Mediated N6-Methyladenosine Modification Is Involved in Oxidative Stress in Human Aortic Dissection
Fanxing Yin, Kun Liu, Wanfu Peng, et al.
Oxidative Medicine and Cellular Longevity (2023) Vol. 2023, pp. 1-23
Open Access | Times Cited: 10
Changes in m6A in Steatotic Liver Disease
Belinda J. Petri, Matthew C. Cave, Carolyn M. Klinge
Genes (2023) Vol. 14, Iss. 8, pp. 1653-1653
Open Access | Times Cited: 10
Endothelial downregulation of nuclear m6A reader YTHDC1 promotes pulmonary vascular remodeling in sugen hypoxia model of pulmonary hypertension
Hao Zheng, Di Wu, Xiangyu Chen, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e24963-e24963
Open Access | Times Cited: 3
RNA-Binding Proteins in Cardiomyopathies
De‐Li Shi
Journal of Cardiovascular Development and Disease (2024) Vol. 11, Iss. 3, pp. 88-88
Open Access | Times Cited: 3
Emerging roles of the RNA modifications N6-methyladenosine and adenosine-to-inosine in cardiovascular diseases
Vilbert Sikorski, Antti Vento, Esko Kankuri
Molecular Therapy — Nucleic Acids (2022) Vol. 29, pp. 426-461
Open Access | Times Cited: 16
PKM2 deficiency exacerbates gram-negative sepsis-induced cardiomyopathy via disrupting cardiac calcium homeostasis
Le Ni, Bo-Wen Lin, Meiting Shen, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 10
Critical roles of m6A methylation in cardiovascular diseases
Xinmin Zhang, He Cai, Xu He, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 6
Relationship between protein arginine methyltransferase and cardiovascular disease (Review)
Sisi Zheng, Congcong Zeng, Ailing Huang, et al.
Biomedical Reports (2022) Vol. 17, Iss. 5
Open Access | Times Cited: 9
N-methyladenosine modification in ischemic stroke: Functions, regulation, and therapeutic potential
Fei Han
Heliyon (2024) Vol. 10, Iss. 3, pp. e25192-e25192
Open Access | Times Cited: 1
m6A RNA methyltransferase METTL16 induces Cr(VI) carcinogenesis and lung cancer development through glutamine biosynthesis and GLUL expression
Yun-Xia Xie, Zhen Li, Zhihao Zhou, et al.
Journal of Hazardous Materials (2024) Vol. 480, pp. 136093-136093
Open Access | Times Cited: 1
YTHDC1 Mitigates Apoptosis in Bone Marrow Mesenchymal Stem Cells by Inhibiting NfƙBiα and Augmenting Cardiac Function Following Myocardial Infarction
Weiyu Han, Weidong Xiong, Weixing Sun, et al.
Cell Transplantation (2024) Vol. 33
Open Access | Times Cited: 1
RNA modifications: emerging players in the regulation of reproduction and development
Junfei Wen, Qifan Zhu, Yong Liu, et al.
Acta Biochimica et Biophysica Sinica (2024)
Open Access | Times Cited: 1
Knockdown of IGF2BP3 inhibits the tumorigenesis of gallbladder cancer and modifies tumor microenvironment
Yiyu Qin, Mingdi Zhang, Haiming Lei, et al.
Drug Development Research (2022) Vol. 83, Iss. 8, pp. 1831-1844
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top